Pharmaceutical Company

Sun Pharma Q2 Earnings: Innovative Medicine Sales Surpass Generics, Here’s What You Need to Know

BY Outlook Business Desk

Shutterstock : Mounjaro Weight Loss Medicine

US Pharma Firm Eli Lilly Partners with Cipla to Sell Weight-loss Drug in India under Brand Name ‘Yurpeak’

BY Outlook Business Desk

Rubicon Research IPO Receives 84% Subscription on Day 2

Rubicon Research IPO Receives 84% Subscription on Day 2

BY PTI

Sun Pharma

Sun Pharma Q1 Net Profit Falls 20% to ₹2,279 Crore

BY PTI

sailife : Sai Life Sciences

Nippon India MF, BlackRock, Societe Generale, Others Buy 10 % Stake in Sai Life for Rs 1,505 Crore

BY PTI

FreePik : Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Signs Rs 517 Crore Supply Mandate With Thailand Firm

BY PTI

LinkedIn/@Sun Pharmaceuticals : Sun Pharmaceutical Industries

Sun Pharma Elevates Kirti Ganorkar as MD; Shanghvi to Continue as Executive Chairman

BY PTI

Advertisement

sunpharma : Sun Pharma is a leading global specialty generic company, with global revenue of US$ 5.8 billion

Sun Pharma to Invest $25 Million in Pharmazz Inc; Raises Stake to 22.7 %

BY PTI

NGL Fine-Chem, Promoters Settle Disclosure Lapses Case with SEBI; Pay Rs 92.21 Lakh

NGL Fine-Chem, Promoters Settle Disclosure Lapses Case with SEBI; Pay Rs 92.21 Lakh

BY PTI

Mankind Pharma Q2 Net Profit Rises 29 % to Rs 659 Crore; Revenue Up 13.6 %

Mankind Pharma Q2 Net Profit Rises 29 % to Rs 659 Crore; Revenue Up 13.6 %

BY PTI

Hospitality Industry’s Pre-Covid Level Recovery Expected by FY24: ICRA

Leading 25 Domestic Pharma Cos Expected To See 9-11% Revenue Growth In FY24: Icra

BY Press Trust of India

Digital Vision Pharma

Natco Pharma Q1 Net Profit Rises 31.2% To Rs 420.3 Cr

BY PTI

Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval

Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval

BY Press Trust of India

Source: Shutterstock

CBI Arrests Joint Drug Controller For Alleged Bribery To Favour Biocon Biologics' Medicine

BY Press Trust of India

Advertisement

Lupin Gets USFDA Nod For Generic Drug

BY Press Trust of India

Zydus Gets USFDA Nod For Generic Antacid

Zydus Gets USFDA Nod For Generic Antacid

BY Press Trust of India

Aurobindo Pharma Profit Falls 28% To Rs 576 Crore In March Quarter

Aurobindo Pharma Profit Falls 28% To Rs 576 Crore In March Quarter

BY PTI

Dr Reddys PAT Down 76% At Rs 87.5 Crore In March Quarter

Dr Reddy's PAT Down 76% At Rs 87.5 Crore In March Quarter

BY Press Trust of India

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

BY PTI

Glenmark Gets Tentative Approval From USFDA For Generic Psoriasis Foam

Glenmark Gets Tentative Approval From USFDA For Generic Psoriasis Foam

BY PTI

Pharmaceutical Sector

Alembic Subsidiary Gets USFDA Nod For Plaque Psoriasis Treatment Foam

BY PTI

Advertisement

Aurobindo, Sun Pharma Recall Products In US Market

Aurobindo, Sun Pharma Recall Products In US Market

BY PTI

File Photo.

Lupin Launches Generic Contraceptive Drug In The US

BY Press Trust of India

File Photo.

Lupin Acquires Portfolio Of Brands From Anglo-French Drugs & Industries

BY Press Trust of India

Alembic Pharma has received 23 approvals year to date.

Alembic Pharma Gets USFDA Nod For Lacosamide Tablet

BY Press Trust of India

These are generic versions of Vimpat tablets of the corresponding strengths of UCB, Inc.

Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

BY Press Trust of India

Adar Poonawalla is the chief of the Serum Institute of India.

Wockhardt, SII Join Hands To Set Up Vaccine Manufacturing Plant In UK

BY Press Trust of India

Pharmaceutical Sector.

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

BY Press Trust of India

Advertisement

The US market for colchicine tablets USP, 0.6 mg is stood at around $85 million.

Strides Pharma Unit Gets USFDA For Generic Product

BY Press Trust of India

Following this development Biocon shares fell as much as 8 per cent to hit an intraday low of Rs 362

Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

BY Outlook Business Desk

India exported over $181 million worth of pharmaceutical goods to Ukraine in FY 21.

Indian Pharma Exporters In Wait And Watch Mode As Russia Invades Ukraine

BY PTI

J&J saw sales of its blood cancer treatment Darzalex jump 31 per cent to about $1.65 billion.

Prescription Drugs, Medical Devices Boost Johnson&Johnson Sales In Q4

BY AP

load more stories